Learn More
About Orchestra
Orchestra Life Sciences is a technical consultancy. We provide strategic support and scientific expertise to advance pharmaceutical therapies for cancer and rare disease. Orchestra offers services instrumental to clients in nuclear medicine, radiation oncology, cell and gene therapies, regenerative medicines, and biotechnology. We work in concert with our clients to provide unparalleled expertise; speeding time to market.
Align
Our team of experts help clients align business strategies, regulatory approaches, engineering processes, and go-to-market plans.
Accelerate
We accelerate projects by streamlining supply chains, facilitating business relationships, and guiding regulatory compliance.
Achieve
We provide the right expertise at the right time to execute challenging projects, enable effective decision-making, and solve complex technical problems to achieve client goals.
Discover
Our Services
Orchestra’s team of consultants provide end-to-end expertise and support to bring commercial therapies to market
Find Out
Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Proven track record of successful project execution
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations
Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations
Learn More
OUR CLIENTS
Orchestra serves clients on multiple continents in the disciplines of:
- Cell and Gene Therapy
- Biotechnology
- Radioligand Therapy
- Nuclear Medicine
- Radiation Oncology
- Fusion
Meet Our
Executive Management
Sumit Verma
Co-Founder & Partner
Emilie Pelletier
Co-Founder & CEO
Castor Armesto
Chief Strategy Officer & Partner
Meet Our
Our Team
Becky Cooper
Director of Quality Assurance and Compliance
Ernie Banks
Senior Program Manager & OPEX Leader
Strategic Project Director
Sandra Boyd
Senior Quality Director
Clement Cheung
Senior Consultant, Process Chemistry
Dale Simpson
Senior Advisor
Greg Bushman
Senior Consultant, Radiopharmaceutical Manufacturing
Lakeisha Green
Project Manager
Robert Matteoni
Project Manager
Ralph Butler
Senior Advisor
Sterling Marshall
Quality Engineer and Instrumentation
John schmitz
Senior Project Director
Sam Meer
Vice-President Strategy and Supply chain
Michael Blackton
QA Executive
Kim Prefontaine
Executive Administrative Assistant
Timo Henk
Senior Engineer
Cristian Boas
Senior Radiochemist
Eriselda Leka
Quality Engineer
Erin Maniscalco
Junior Designer
Bruna Teixeira
Quality Engineer
Savani Nagarkar
Project Engineer
Jessica Giffey
Vice-President – Radiopharmaceutical programs
Hiten Patel
Director, Manufacturing operations
Nicholas Baldasaro
Project Director
Brian Kirk
Vice President, Construction
Joe Spinelli
Senior Director, Engineering
Keith Thompson
Senior Technical Program Manager
Lovey Bagga
Associate Director, Finance
Michelle Hackmann
Chief of Staff
Stephanie Bladdick
Project Manager
Zach Lewis
Director, Regulatory and Compliance
Be Up To Date

Execution Is The Contraint: Why Infrastrucure Now Defines Success In Advanced Therapies
Execution as a Design Problem in Advanced Therapies Advanced therapies are being shaped by constraints that sit outside the lab. Scientific progress continues, but outcomes

How Advanced Therapies and Radiopharmaceuticals Redefined the Future of Drug Development
Orchestra Life Sciences’ Year-End Perspectives The life sciences sector entered 2025 with considerable momentum and concluded the year having experienced meaningful scientific, regulatory, and operational
Closing the Talent Gap in Advanced Therapies: Why Workforce Development Is an Industry Imperative
Advanced therapies are rapidly evolving, but talent development has not kept pace. Across the US, companies struggle to hire and retain operators, quality specialists, and

Orchestra Life Sciences Expands into Europe to Support Radiopharmaceutical Execution, Appoints Vinod Ramnandanlal as President and Managing Director
The expansion builds on existing client engagements and growing demand for regional execution support. The expansion builds on existing client engagements and growing demand for
Orchestra Life Sciences Relocates Global Headquarters to Philadelphia’s Navy Yard
Relocation reflects Orchestra’s commitment to innovation, ecosystem growth, and building the advancedtherapy workforce of the future Philadelphia, PA, October 22, 2025 — Orchestra Life Sciences

BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell TherapyFacility Development
Princeton, NJ, January 14– BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic partnership with Orchestra Life Sciences (OLS),
Feel Free To